Protara Therapeutics, Inc. - stock earnings
TARA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -10.2 million USD | ? USD |
| 2023Q3 | -9.9 million USD | ? USD |
| 2023Q2 | -11.3 million USD | ? USD |
| 2023Q1 | -8.4 million USD | ? USD |
| 2022Q4 | -38.9 million USD | ? USD |
| 2022Q3 | -7.4 million USD | ? USD |
| 2022Q2 | -8.2 million USD | ? USD |
| 2022Q1 | -10.6 million USD | ? USD |
| 2021Q4 | -10.2 million USD | ? USD |
| 2021Q3 | -10.8 million USD | ? USD |
| 2021Q2 | -12.8 million USD | ? USD |
| 2021Q1 | -13.5 million USD | ? USD |
| 2020Q4 | -8.8 million USD | ? USD |
| 2020Q3 | -8.0 million USD | ? USD |
| 2020Q2 | -7.1 million USD | ? USD |
| 2020Q1 | -10.1 million USD | ? USD |
| 2019Q4 | 2.6 million USD | ? USD |
| 2019Q3 | -2.4 million USD | ? USD |
| 2019Q2 | -1.4 million USD | ? USD |
| 2019Q1 | -6.5 million USD | ? USD |
| 2018Q4 | -5.3 million USD | ? USD |
| 2018Q3 | -4.5 million USD | ? USD |
| 2018Q2 | -4.9 million USD | ? USD |
| 2018Q1 | -6.1 million USD | ? USD |
| 2017Q4 | -5.6 million USD | ? USD |
| 2017Q3 | -12.3 million USD | ? USD |
| 2017Q2 | -5.6 million USD | ? USD |
| 2017Q1 | -6.5 million USD | ? USD |
| 2016Q4 | -7.0 million USD | ? USD |
| 2016Q3 | -7.1 million USD | ? USD |
| 2016Q2 | -7.9 million USD | ? USD |
| 2016Q1 | -6.6 million USD | ? USD |
| 2015Q4 | -6.3 million USD | ? USD |
| 2015Q3 | -5.4 million USD | ? USD |
| 2015Q2 | -5.1 million USD | ? USD |
| 2015Q1 | -4.6 million USD | ? USD |
| 2014Q4 | 7.2 million USD | ? USD |
| 2014Q3 | -7.5 million USD | 2.9 million USD |
TARA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -40.4 million USD | ? USD |
| 2022 | -64.8 million USD | ? USD |
| 2021 | -47.1 million USD | ? USD |
| 2020 | -33.5 million USD | ? USD |
| 2019 | -14.7 million USD | ? USD |
| 2018 | -25.4 million USD | ? USD |
| 2017 | -30.0 million USD | ? USD |
| 2016 | -28.5 million USD | ? USD |
| 2015 | -21.4 million USD | ? USD |
| 2014 | -3.3 million USD | 2.9 million USD |
TARA
Price: $2.89
52 week price:
Earnings Per Share: -3.57 USD
P/E Ratio: -0.45
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 2909
Market Capitalization: 32.5 million